AWHL

SEC source: 0001641172-25-002278 · ownership.xml · derivative · entry 2

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,312

Underlying: Common Stock · 5,313 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.

F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,313 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,313 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4.

SEC source: 0001641172-25-002278 · ownership.xml · nonDerivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,677

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,313 of which vested on March 31, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.

SEC source: 0001641172-25-002227 · ownership.xml · derivative · entry 1

Beausang Ellen · CIK 0002061533 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,458

Underlying: Common Stock · 6,458 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock

F2 · derivative.exercise_date: 1,615 RSUs will vest on March 31, 2025 and 4,843 RSUs will vest on date of the annual shareholders' meeting, subject to the Reporting Person's continued service to Aspira Women's Health Inc. through the applicable vesting dates.

F2 · derivative.expiration_date: 1,615 RSUs will vest on March 31, 2025 and 4,843 RSUs will vest on date of the annual shareholders' meeting, subject to the Reporting Person's continued service to Aspira Women's Health Inc. through the applicable vesting dates.

SEC source: 0000908834-25-000098 · form4.xml · derivative · entry 3

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: Not disclosed

Underlying: Common Stock · 800,000 shares

Expires 2030-03-06

F2 · derivative.underlying: On March 6, 2025, the Issuer issued to the Living Trust in a private transaction a Senior Secured Convertible Note due 2030 in the principal amount of $200,000 (the "Convertible Note"). Each $0.25 principal amount of the Convertible Note is convertible by its holder at any time prior to maturity into one "Phase 1 Unit," consisting of (i) one share of Common Stock and (ii) a warrant to purchase, on the terms set forth therein, 2.25 shares of Common Stock.

F2 · derivative.underlying_shares: On March 6, 2025, the Issuer issued to the Living Trust in a private transaction a Senior Secured Convertible Note due 2030 in the principal amount of $200,000 (the "Convertible Note"). Each $0.25 principal amount of the Convertible Note is convertible by its holder at any time prior to maturity into one "Phase 1 Unit," consisting of (i) one share of Common Stock and (ii) a warrant to purchase, on the terms set forth therein, 2.25 shares of Common Stock.

F1 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust") and in such capacity may be deemed to beneficially own the securities held by the Living Trust.

SEC source: 0001859810-25-000002 · primary_doc.xml · nonDerivative · entry 2

Milligan Sandra · CIK 0001859810 · Interim CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,644

F2 · kind: This line reflects the tax withholding on the vesting of RSUs that vested on December 31, 2024.

F5 · kind: This report is being filed to correct the number of shares held after tax withholding on the vesting of RSUs that vested on December 31, 2024.

SEC source: 0001973204-25-000001 · primary_doc.xml · derivative · entry 2

Herchuk Jannie Prestridge · CIK 0001973204 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,875

Underlying: Common Stock · 8,437 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.

F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,437 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,437 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4.

SEC source: 0001973204-25-000001 · primary_doc.xml · nonDerivative · entry 1

Herchuk Jannie Prestridge · CIK 0001973204 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,627

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,437 of which vested on December 31, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.

SEC source: 0001911051-25-000001 · primary_doc.xml · derivative · entry 2

Fralick Celeste Rachelle · CIK 0001911051 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 5,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.

F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4.

SEC source: 0001911051-25-000001 · primary_doc.xml · nonDerivative · entry 1

Fralick Celeste Rachelle · CIK 0001911051 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,665

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on December 31, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.

SEC source: 0001979704-25-000001 · primary_doc.xml · derivative · entry 2

Parnell Winfred · CIK 0001979704 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,312

Underlying: Common Stock · 5,157 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.

F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 20,625 RSUs, 5,157 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 20,625 RSUs, 5,157 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4.

SEC source: 0001979704-25-000001 · primary_doc.xml · nonDerivative · entry 1

Parnell Winfred · CIK 0001979704 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,897

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 20,625 RSUs, 5,157 of which vested on December 31, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.

SEC source: 0001688530-25-000001 · primary_doc.xml · derivative · entry 2

Cavanaugh Stefanie L. · CIK 0001688530 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,875

Underlying: Common Stock · 5,937 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.

F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 23,750 RSUs, 5,937 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 23,750 RSUs, 5,937 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4.

SEC source: 0001688530-25-000001 · primary_doc.xml · nonDerivative · entry 1

Cavanaugh Stefanie L. · CIK 0001688530 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,851

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 23,750 RSUs, 5,937 of which vested on December 31, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.

SEC source: 0002031593-25-000001 · primary_doc.xml · derivative · entry 2

Ragard John Phillip · CIK 0002031593 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,687

Underlying: Common Stock · 4,844 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.

F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4.

SEC source: 0002031593-25-000001 · primary_doc.xml · nonDerivative · entry 1

Ragard John Phillip · CIK 0002031593 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,047

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on December 31, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.

SEC source: 0001859810-25-000001 · primary_doc.xml · derivative · entry 2

Milligan Sandra · CIK 0001859810 · Interim CEO & President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.

F3 · derivative.exercise_date: On October 28, 2024, the reporting person was granted 20,000 RSUs, which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On October 28, 2024, the reporting person was granted 20,000 RSUs, which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4.

SEC source: 0001859810-25-000001 · primary_doc.xml · nonDerivative · entry 1

Milligan Sandra · CIK 0001859810 · Interim CEO & President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On October 28, 2024, the reporting person was granted 20,000 RSUs, which vested on December 31, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on October 28, 2024.

SEC source: 0001562180-25-000277 · primarydocument.xml · derivative · entry 2

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,625

Underlying: Common Stock · 5,312 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.

F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,312 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,312 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4.

SEC source: 0001562180-25-000277 · primarydocument.xml · nonDerivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,364

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,312 of which vested on December 31, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.

SEC source: 0001859810-25-000002 · primary_doc.xml · derivative · entry 3

Milligan Sandra · CIK 0001859810 · Interim CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.

F4 · derivative.exercise_date: On October 28, 2024, the reporting person was granted 20,000 RSUs, which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4.

F4 · derivative.expiration_date: On October 28, 2024, the reporting person was granted 20,000 RSUs, which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4.

SEC source: 0001859810-25-000002 · primary_doc.xml · nonDerivative · entry 1

Milligan Sandra · CIK 0001859810 · Interim CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On October 28, 2024, the reporting person was granted 20,000 RSUs, which vested on December 31, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on October 28, 2024.

SEC source: 0001859810-24-000005 · primary_doc.xml · derivative · entry 1

Milligan Sandra · CIK 0001859810 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2034-11-12

SEC source: 0001562180-24-007697 · primarydocument.xml · derivative · entry 1

Kallassy John A · CIK 0001379818 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2027-11-12

SEC source: 0001859810-24-000004 · primary_doc.xml · derivative · entry 1

Milligan Sandra · CIK 0001859810 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: In accordance with her amended contract effective September 1, 2024, the award will vest 100% on December 31, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

F2 · derivative.expiration_date: In accordance with her amended contract effective September 1, 2024, the award will vest 100% on December 31, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

SEC source: 0001849521-24-000006 · primary_doc.xml · derivative · entry 1

Sandford Nicole · CIK 0001849521 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: In accordance with her amended contract effective September 1, 2024, the award will vest 100% on December 31, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

F2 · derivative.expiration_date: In accordance with her amended contract effective September 1, 2024, the award will vest 100% on December 31, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

SEC source: 0001688530-24-000002 · primary_doc.xml · derivative · entry 2

Cavanaugh Stefanie L. · CIK 0001688530 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,812

Underlying: Common Stock · 5,938 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.

F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 23,750 RSUs, 5,938 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 23,750 RSUs, 5,938 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4.

SEC source: 0001688530-24-000002 · primary_doc.xml · nonDerivative · entry 1

Cavanaugh Stefanie L. · CIK 0001688530 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,914

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 23,750 RSUs, 5,938 of which vested on September 30, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.

SEC source: 0001973204-24-000001 · primary_doc.xml · derivative · entry 2

Herchuk Jannie Prestridge · CIK 0001973204 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,312

Underlying: Common Stock · 8,438 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.

F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,438 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,438 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4.

SEC source: 0001973204-24-000001 · primary_doc.xml · nonDerivative · entry 1

Herchuk Jannie Prestridge · CIK 0001973204 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,190

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,438 of which vested on September 30, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.

SEC source: 0001979704-24-000001 · primary_doc.xml · derivative · entry 2

Parnell Winfred · CIK 0001979704 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,469

Underlying: Common Stock · 5,156 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.

F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 20,625 RSUs, 5,156 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 20,625 RSUs, 5,156 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4.

SEC source: 0001979704-24-000001 · primary_doc.xml · nonDerivative · entry 1

Parnell Winfred · CIK 0001979704 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,740

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 20,625 RSUs, 5,156 of which vested on September 30, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.

SEC source: 0002031593-24-000001 · primary_doc.xml · derivative · entry 2

Ragard John Phillip · CIK 0002031593 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,531

Underlying: Common Stock · 4,844 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.

F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4.

SEC source: 0002031593-24-000001 · primary_doc.xml · nonDerivative · entry 1

Ragard John Phillip · CIK 0002031593 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,203

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on September 30, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.

SEC source: 0001911051-24-000001 · primary_doc.xml · derivative · entry 2

Fralick Celeste Rachelle · CIK 0001911051 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 5,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.

F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4.

SEC source: 0001911051-24-000001 · primary_doc.xml · nonDerivative · entry 1

Fralick Celeste Rachelle · CIK 0001911051 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,665

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on September 30, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.

SEC source: 0001562180-24-007233 · primarydocument.xml · derivative · entry 2

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,937

Underlying: Common Stock · 5,313 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.

F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,313 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,313 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4.

SEC source: 0001562180-24-007233 · primarydocument.xml · nonDerivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,052

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,313 of which vested on September 30, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.

SEC source: 0002031593-24-000002 · primary_doc.xml · derivative · entry 2

Ragard John Phillip · CIK 0002031593 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,531

Underlying: Common stock · 4,844 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.

F4 · kind: This report is being filed to correct the derivative securities from acquired to disposed.

F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4.

SEC source: 0002031593-24-000002 · primary_doc.xml · nonDerivative · entry 1

Ragard John Phillip · CIK 0002031593 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,203

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on September 30, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.

SEC source: 0000950170-24-100573 · ownership.xml · derivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,250

Underlying: Common Stock · 21,250 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The award will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and the date of the annual shareholders' meeting, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F2 · derivative.expiration_date: The award will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and the date of the annual shareholders' meeting, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

SEC source: 0000950170-24-100348 · ownership.xml · derivative · entry 1

Parnell Winfred · CIK 0001979704 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,625

Underlying: Common Stock · 20,625 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The award will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and the date of the annual shareholders' meeting, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F2 · derivative.expiration_date: The award will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and the date of the annual shareholders' meeting, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

SEC source: 0000950170-24-100346 · ownership.xml · derivative · entry 1

Ragard John Phillip · CIK 0002031593 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,375

Underlying: Common Stock · 19,375 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The award will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and the date of the annual shareholders' meeting, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F2 · derivative.expiration_date: The award will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and the date of the annual shareholders' meeting, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

SEC source: 0000950170-24-100341 · ownership.xml · derivative · entry 1

Herchuk Jannie Prestridge · CIK 0001973204 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,750

Underlying: Common Stock · 33,750 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The award will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and the date of the annual shareholders' meeting, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F2 · derivative.expiration_date: The award will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and the date of the annual shareholders' meeting, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

SEC source: 0000950170-24-100339 · ownership.xml · derivative · entry 1

Fralick Celeste Rachelle · CIK 0001911051 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The award will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and the date of the annual shareholders' meeting, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F2 · derivative.expiration_date: The award will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and the date of the annual shareholders' meeting, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

SEC source: 0000950170-24-100336 · ownership.xml · derivative · entry 1

Cavanaugh Stefanie L. · CIK 0001688530 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,750

Underlying: Common Stock · 23,750 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The award will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and the date of the annual shareholders' meeting, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F2 · derivative.expiration_date: The award will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and the date of the annual shareholders' meeting, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

SEC source: 0000950170-24-100343 · ownership.xml · derivative · entry 1

Kallassy John A · CIK 0001379818 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2034-08-15

F1 · derivative.exercise_date: The stock option will vest in six equal amounts, with 1/6 of the grant vesting upon the grant date and an additional 1/6 vesting each month thereafter.

SEC source: 0000950170-24-096277 · ownership.xml · nonDerivative · entry 1

Fralick Celeste Rachelle · CIK 0001911051 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,665

F1 · shares: The shares of common stock represent restricted stock units with the contingent right to receive one share of common stock of Aspira Women's Health Inc. for each restricted stock unit. The restricted stock unit vested in full on August 12, 2024.

SEC source: 0000950170-24-096268 · ownership.xml · nonDerivative · entry 1

Parnell Winfred · CIK 0001979704 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,584

F1 · shares: The shares of common stock represent restricted stock units with the contingent right to receive one share of common stock of Aspira Women's Health Inc. for each restricted stock unit. The restricted stock unit vested in full on August 12, 2024.

SEC source: 0000950170-24-096259 · ownership.xml · nonDerivative · entry 1

Herchuk Jannie Prestridge · CIK 0001973204 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,752

F1 · shares: The shares of common stock represent restricted stock units with the contingent right to receive one share of common stock of Aspira Women's Health Inc. for each restricted stock unit. The restricted stock unit vested in full on August 12, 2024.

SEC source: 0000950170-24-096254 · ownership.xml · nonDerivative · entry 1

Cavanaugh Stefanie L. · CIK 0001688530 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,976

F1 · shares: The shares of common stock represent restricted stock units with the contingent right to receive one share of common stock of Aspira Women's Health Inc. for each restricted stock unit. The restricted stock unit vested in full on August 12, 2024.